FDA Proposals to Permit the Use of Disease-specific Health Claims on Food Labels: Hearing Before a Subcommittee of the Committee on Government Operations, House of Representatives, One Hundredth Congress, First Session, December 10, 1987U.S. Government Printing Office, 1988 - 471 pages Abstract: This hearing discusses proposals made FDA to permit disease-specific health claims on food labels. Statements from medical associations and government agencies examine the effect and legality of allowing disease-specific health claims on food labels. |
Other editions - View all
Common terms and phrases
adequate advertising agency agency's All-Bran American appropriate bran cancer cereals CFSAN Chairman cholesterol claims on food Commissioner Committee concerning CONGRESS THE LIBRARY consensus consumers Cosmetic Act criteria cure develop diet and health dietary fiber dietary supplements discuss disease Dockets document draft Drug Administration drug provisions effective enforcement evaluating FDA's Federal Food Federal Register fiber Food and Drug food labeling food products Food Safety health claims health information health-related claims health-related information information on food intake issue Kellogg Kellogg Company LIBRARY OF CONGRESS manufacturers memorandum messages on food misbranded misleading mitigation National Cancer Institute nonmisleading notice nutrients nutrition labeling prevention promotional proposed rule public health messages recommendations regulatory relationship between diet requirements risk saturated fat SCARLETT scientific evidence sodium specific foods Subcommittee substantial suggested Ted Weiss therapeutic total diet total dietary pattern vitamins WEISS YOUNG
Popular passages
Page 165 - Formulary, or any supplement to any of them ; and (2) articles intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease in man or other animals; and (3) articles (other than food) intended to affect the structure or any function of the body of man or other animals...
Page 357 - drug," as used in this Act, shall include all medicines and preparations recognized in the United States Pharmacopoeia or National Formulary for internal or external use, and any substance or mixture of substances intended to be used for the cure, mitigation, or prevention of disease of either man or other animals. The term
Page 360 - ... or (2) any drug the composition of which is such that such drug, as a result of investigations to determine its safety for use under such conditions, has become so recognized, but which has not, otherwise than in such investigations, been used to a material extent or for a material time under such conditions. (o) The term "contaminated with filth...
Page 354 - Unless its labeling bears (1) adequate directions for use; and (2) such adequate warnings against use in those pathological conditions or by children where its use may be dangerous to health, or against unsafe dosage or methods or duration of administration or application, in such manner and form, as are necessary for the protection of users...
Page 347 - If an article is alleged to be misbranded because the labeling is misleading, then in determining whether the labeling is misleading there shall be taken into account (among other things) not only representations made or suggested by statement, word, design, device, or any combination thereof, but also the extent to which the labeling fails to reveal facts material in the light of such representations...
Page 347 - ... fails to reveal facts material in the light of such representations or material with respect to consequences which may result from the use of the article to which the labeling or advertising relates under the conditions of use prescribed in the labeling or advertising thereof or under such conditions of use as are customary or usual.
Page 354 - Provided, That where any requirement of clause (1) of this paragraph, as applied to any drug or device, is not necessary for the protection of the public health, the Secretary shall promulgate regulations exempting such drug or device from such requirement.
Page 136 - ... held under the auspices of the Committee on Public Health of the New York Academy of Medicine, the transactions of which have been edited ably last year by HD Kruse (Hoeber-Harper).
Page 347 - ... not only representations made or suggested by statement, word, design, device, sound, or any combination thereof, but also the extent to which the advertisement fails to reveal facts material in the light of such representations or material with respect to consequences which may result from the use of the commodity to which the advertisement relates under the conditions prescribed in said advertisement, or under such conditions as are customary or usual.
Page 63 - new drug" means (1) any drug the composition of which is such that such drug is not generally recognized, among experts qualified by scientific training and experience to evaluate the safety of drugs, as safe for use under the conditions prescribed, recommended, or suggested in the labeling thereof...